HI
AMRX icon

Horizon Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Horizon Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Sell
7,086
-75,160
-91% -$1.03M ﹤0.01% 1092
2026
Q1 		$1.02M Buy
+82,246
New +$1.1M 0.01% 648

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Horizon Investments's AMRX Position: Q2 2026 in Review

Horizon Investments reduced its Amneal Pharmaceuticals (AMRX) stake by 91% in Q2 2026, selling an estimated $1.03M and leaving 7,086 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Horizon Investments first reported a position in AMRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.02M in Q1 2026. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Horizon Investments held 7,086 shares of Amneal Pharmaceuticals worth $123K as of Q2 2026.
  • Horizon Investments sold 75,160 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.03M.
  • Amneal Pharmaceuticals made up ﹤0.01% of Horizon Investments's portfolio in Q2 2026, its #1092 holding.
  • Horizon Investments first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Horizon Investments's Amneal Pharmaceuticals position peaked at $1.02M in Q1 2026.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.